Suppr超能文献

金雀异黄素 8-C-葡萄糖苷作为 SARS-CoV-2 感染的进入抑制剂:分子建模研究。

Fisetin 8-C-glucoside as entry inhibitor in SARS CoV-2 infection: molecular modelling study.

机构信息

School of Biochemical Engineering, Indian Institute of Technology, Banaras Hindu University, Varanasi, India.

Department of Pharmacology, All India Institute of Medical Sciences, Gorakhpur, India.

出版信息

J Biomol Struct Dyn. 2022 Jul;40(11):5128-5137. doi: 10.1080/07391102.2020.1868335. Epub 2020 Dec 31.

Abstract

Coronaviruses are RNA viruses that infect varied species including humans. TMPRSS2 is gateway for SARS CoV-2 entry into the host cell. It causes proteolytic activation of spike protein and discharge of the peptide into host cell. The TMPRSS2 inhibition could be one of the approaches to stop the viral entry, therefore, interaction pattern and binding energies for Fisetin and TMPRSS2 have been explored in the present study. TMPRSS2 peptide was used for homology modelling and then for further study. Molecular docking score and MMGBSA Binding energy of Fisetin was better than Nafamostat, a known inhibitor of TMPRSS2. Post docking MM-GBSA free energy for Fisetin and Nafamostat was -42.78 and -21.11 kcal/mol, respectively. Fisetin forms H bond with Val 25, His 41, Lys 42, Lys 45, Glu 44, Ser186. Nafamostat formed H bonds with Lys 85, Asp 90, Asp 203. RMSD plots of TMPRSS2, TMPRSS2-Fisetin and TMPRSS2-Nafamostat complex showed stable profile with very small fluctuation during entire simulation of 150 ns. Significant decrease in TMPRSS2-Fisetin and TMPRSS2-Nafamostat complex fluctuation occurred around His 41, Glu 44, Gly 136, Ser 186 in RMSF study. During simulation Fisetin interaction was observed with residues Val 25, His 41, Glu 44, Lys 45, Lys 87, Gly 136, Gln 183, Ser 186 likewise interaction of Nafamostat with Lys 85, Asp 90, Asn 163, Asp 203 and Ser 205. Post simulation MM-GBSA free energy was found to be -51.87 ± 4.3 and -48.23 ± 4.39 kcal/mol for TMPRSS2 with Fisetin and Nafamostat, respectively.Communicated by Ramaswamy H. Sarma.

摘要

冠状病毒是一种感染多种物种的 RNA 病毒,包括人类。TMPRSS2 是 SARS CoV-2 进入宿主细胞的门户。它导致刺突蛋白的蛋白水解激活,并将肽释放到宿主细胞中。TMPRSS2 的抑制可能是阻止病毒进入的方法之一,因此,本研究探索了非那雄胺和 TMPRSS2 的相互作用模式和结合能。使用 TMPRSS2 肽进行同源建模,然后进行进一步研究。非那雄胺的分子对接评分和 MMGBSA 结合能优于 TMPRSS2 的已知抑制剂那法莫司他。非那雄胺和那法莫司他的对接后 MM-GBSA 自由能分别为-42.78 和-21.11 kcal/mol。非那雄胺与 Val 25、His 41、Lys 42、Lys 45、Glu 44、Ser186 形成氢键。那法莫司他与 Lys 85、Asp 90、Asp 203 形成氢键。TMPRSS2、TMPRSS2-非那雄胺和 TMPRSS2-那法莫司他复合物的 RMSD 图谱显示,在整个 150 ns 的模拟过程中,图谱稳定,波动非常小。在 RMSF 研究中,TMPRSS2-Fisetin 和 TMPRSS2-Nafamostat 复合物的波动显著减少,发生在 His 41、Glu 44、Gly 136、Ser 186 周围。在模拟过程中,观察到非那雄胺与 Val 25、His 41、Glu 44、Lys 45、Lys 87、Gly 136、Gln 183、Ser 186 相互作用,那法莫司他与 Lys 85、Asp 90、Asn 163、Asp 203 和 Ser 205 相互作用。模拟后,TMPRSS2 与非那雄胺和那法莫司他的 MM-GBSA 自由能分别为-51.87±4.3 和-48.23±4.39 kcal/mol。由 Ramaswamy H. Sarma 交流。

相似文献

1
Fisetin 8-C-glucoside as entry inhibitor in SARS CoV-2 infection: molecular modelling study.
J Biomol Struct Dyn. 2022 Jul;40(11):5128-5137. doi: 10.1080/07391102.2020.1868335. Epub 2020 Dec 31.
6
Leucoefdin a potential inhibitor against SARS CoV-2 M.
J Biomol Struct Dyn. 2021 Aug;39(12):4427-4432. doi: 10.1080/07391102.2020.1777903. Epub 2020 Jun 17.

引用本文的文献

2
Discovery of Histone Deacetylase Inhibitor Using Molecular Modeling and Free Energy Calculations.
ACS Omega. 2022 May 24;7(22):18786-18794. doi: 10.1021/acsomega.2c01572. eCollection 2022 Jun 7.

本文引用的文献

1
Leucoefdin a potential inhibitor against SARS CoV-2 M.
J Biomol Struct Dyn. 2021 Aug;39(12):4427-4432. doi: 10.1080/07391102.2020.1777903. Epub 2020 Jun 17.
2
Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells.
J Biomol Struct Dyn. 2022 Jan;40(1):1-13. doi: 10.1080/07391102.2020.1775704. Epub 2020 Jun 16.
3
First comprehensive computational analysis of functional consequences of SNPs in susceptibility to SARS-CoV-2 among different populations.
J Biomol Struct Dyn. 2021 Jul;39(10):3576-3593. doi: 10.1080/07391102.2020.1767690. Epub 2020 Jun 1.
4
An evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets.
J Biomol Struct Dyn. 2021 Jun;39(9):3244-3255. doi: 10.1080/07391102.2020.1762741. Epub 2020 May 13.
5
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
7
TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections.
Biochimie. 2017 Nov;142:1-10. doi: 10.1016/j.biochi.2017.07.016. Epub 2017 Aug 1.
8
Molecular modeling and docking of small molecule inhibitors against NEK2.
Bioinformation. 2016 Apr 10;12(2):62-68. doi: 10.6026/97320630012062. eCollection 2016.
10
Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field.
J Chem Theory Comput. 2010 May 11;6(5):1509-19. doi: 10.1021/ct900587b. Epub 2010 Apr 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验